Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Oct 19, 2020 9:55 AM - Oct 20, 2020 5:30 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA Annual Canadian Meeting

Session 4 Track A: Regulatory Innovation at Health Canada: Advancing Agile Regulations for Drugs and Devices

Session Chair(s)

Judith  Mergl, MSc

Judith Mergl, MSc

Head of Regulatory Affairs and Operational Services, Canada, AbbVie Corporation, Canada

Innovative technologies are dramatically changing the health landscape. This complex, modern health environment requires new regulatory approaches to enable access to novel and innovative health technologies, while continuing to protect patient safety. In this interactive session, Health Canada leadership will discuss key projects in the Department’s Regulatory Innovation Agenda, including modernizing clinical trial regulations, enabling Advanced Therapeutic Products, pursuing agile licensing for drugs and medical devices, and advancing modernization in compliance and enforcement. In addition, the presenters will discuss lessons learned from Health Canada’s agile regulatory response to COVID-19, the impact of the pandemic on the Regulatory Innovation Agenda, and our path forward.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Summarize the key pillars of Health Canada’s Regulatory Innovation Agenda
  • Explain how the Regulatory Innovation Agenda will support access to innovative health technologies
  • Describe agile regulatory measures introduced in response to COVID-19

Speaker(s)

Elizabeth  Toller, MA

Elizabeth Toller, MA

Associate Director General, Policy, Planning and International Affairs Directora, Health Canada, Canada

Regulatory Innovation at Health Canada: Advancing Agile Regulations for Drugs and Devices

Carole  Legare, MD

Carole Legare, MD

Director, Office of Clinical Trials, TPD, Health Canada, Canada

Regulatory Innovation at Health Canada: Advancing agile regulations for drugs and devices

Celia  Lourenco, PhD

Celia Lourenco, PhD

Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada, Canada

Regulatory Innovation at Health Canada: Advancing Agile Regulations for Drugs and Devices

David  Boudreau

David Boudreau

Director General, Medical Devices Directorate, Health Products and Food Branch, Health Canada, Canada

Speaker

Catherine  Hudon, MPA

Catherine Hudon, MPA

, Health Canada, Canada

Speaker

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.